US university psychiatrist loses chairmanship over drug company paymentsBMJ 2009; 338 doi: http://dx.doi.org/10.1136/bmj.a3188 (Published 06 January 2009) Cite this as: BMJ 2009;338:a3188
- Janice Hopkins Tanne
- 1New York
Charles Nemeroff, a psychiatrist and expert in depression and mood and anxiety disorders, has lost his post as chairman of the department of psychiatry and behavioural sciences at Emory University in Atlanta, Georgia, because of payments from drug companies that he had not disclosed.
In October, Dr Nemeroff, who had chaired the department for 17 years, temporarily stepped down after the Senate finance committee found that he had received payments from GlaxoSmithKline and other companies but had not reported them to the university or to the National Institutes of Health as required. Emory then set up a new conflict of interest office (BMJ 2008;337:a2200).
In a statement on 23 December, Emory said that Dr Nemeroff “will remain in the department …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial